Skip to main content
Clinical Trials/NCT00084552
NCT00084552CompletedNot Applicable

Outcomes Following Intensity Modulated Radiation Therapy With And Without Erectile Tissue Dose Sparing For Favorable To Intermediate Risk Prostate Cancer

Fox Chase Cancer Center2 sites in 1 country116 target enrollmentStarted: December 11, 2003Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
116
Locations
2
Primary Endpoint
Erectile Dysfunction Rates

Study Overview

Brief Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Intensity-modulated radiation therapy (radiation directed at the tumor more precisely than in standard radiation therapy) may reduce damage to healthy tissue near the tumor. It is not yet known whether reducing the dose of radiation to erectile tissue will help prevent erectile dysfunction.

PURPOSE: This randomized phase III trial is studying intensity-modulated radiation therapy alone to see how well it works compared to intensity-modulated radiation therapy with reduced doses to erectile tissue in treating patients with stage II prostate cancer.

Detailed Description

OBJECTIVES:

Primary

  • Compare erectile dysfunction in patients with stage T1b-T2c adenocarcinoma of the prostate after treatment with intensity-modulated radiotherapy with vs without dose sparing for erectile tissue.

Secondary

  • Compare biochemical freedom from failure rates, as a measure of prostate cancer control, in patients treated with these regimens.
  • Compare the quality of life of patients treated with these regimens.
  • Determine the association of molecular markers and biochemical freedom from failure rate and other endpoints in patients treated with these regimens.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Erectile Dysfunction Rates

Time Frame: 5 year duration after completion of radiotherapy

Postage Stamp Test -A row of stamps is placed around the base of the penis and the ends are moistened and joined. If the circle is broken in the morning then the subject was recorded as having had a nocturnal erection International Index of Erectile Function (IIEF) Questionnaire * 15-item questionnaire that measures erectile function * Includes companion questionnaire which measures how the partner feels her sexual relationship with the patient has changed since his cancer diagnosis and therapy

Secondary Outcomes

  • Acute GU Toxicity(5 years after treatment)
  • Acute GI Toxicity(5 years after treatment)
  • Percentage of Patients With Freedom From Biochemical Failure(2 years after treatment)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Intensity-Modulated Radiation Therapy With... | Clinical Trial